SEC Form 4 · accession 0001140361-15-023524
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
May 22, 2010
Accepted (ET)
Jun 8, 2015 · 5:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2010 | M | 7,500 | $0.00 | A | 94,067 | D | |
| Common Stock | Jun 7, 2010 | M | 5,000 | $0.00 | A | 99,067 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3 | $0.00 | May 22, 2010 | M | 7,500 | D | May 22, 2010 | — | Common Stock | 7,500 | 25,000 | D |
| Restricted Stock UnitsF4 | $0.00 | Jun 7, 2010 | M | 5,000 | D | Jun 7, 2010 | — | Common Stock | 5,000 | 20,000 | D |
Explanation of responses
- F1Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted May 22, 2008.
- F2Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted June 7, 2007.
- F3Original grant of restricted stock units vest 1/4th each on June 22, 2009, May 22, 2010, May 22, 2011 and May 22, 2012.
- F4Original grant of restricted stock units vest 1/4th each on July 7, 2008, June 7, 2009, June 7, 2010 and June 7, 2011.